Literature DB >> 7598367

Onset of otitis media in the first eight weeks of life in aboriginal and non-aboriginal Australian infants.

J B Boswell1, T G Nienhuys.   

Abstract

Otitis media (OM) is highly prevalent among Aboriginal Australians, in whom eardrum perforations with discharge have been reported in the first 3 months of life. Only one published study, however, has described middle ear status at birth or prior to eardrum perforation in young Aboriginal infants. This prospective study used otoscopy, tympanometry, and hearing tests to compare middle ear status and hearing sensitivity in Aboriginal and non-Aboriginal neonates. Immobile eardrums were observed immediately after birth, but mobility generally appeared within the first week. At examinations at 6 to 8 weeks of age, OM with effusion or acute OM was observed in 95% of 22 Aboriginal infants, but OM with effusion was seen in only 30% of 10 non-Aboriginal infants. There was a clinic record of unilateral perforation in 1 Aboriginal infant only. Hearing impairment was demonstrated by auditory brain stem response in 5 ears, all with evidence of middle ear abnormalities. Improved knowledge and diagnosis of the signs and symptoms of OM will contribute to improvements in the provision of early medical intervention to populations at high risk for early OM.

Entities:  

Mesh:

Year:  1995        PMID: 7598367     DOI: 10.1177/000348949510400708

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  8 in total

1.  Otitis media incidence and risk factors in a population-based birth cohort.

Authors:  Elaina A Macintyre; Catherine J Karr; Mieke Koehoorn; Paul Demers; Lillian Tamburic; Cornel Lencar; Michael Brauer
Journal:  Paediatr Child Health       Date:  2010-09       Impact factor: 2.253

2.  Clinical perspectives on nasopharyngeal morphology in humans.

Authors:  Rebecca Rohde; David R Friedland
Journal:  Anat Rec (Hoboken)       Date:  2022-04-06       Impact factor: 2.227

3.  Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens.

Authors:  Ruth B Thornton; Lea-Ann S Kirkham; Karli J Corscadden; Selma P Wiertsema; Angela Fuery; B Jan Jones; Harvey L Coates; Shyan Vijayasekaran; Guicheng Zhang; Anthony Keil; Peter C Richmond
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

4.  A program to respond to otitis media in remote Australian Aboriginal communities: a qualitative investigation of parent perspectives.

Authors:  Caroline Jones; Mridula Sharma; Samantha Harkus; Catherine McMahon; Mele Taumoepeau; Katherine Demuth; Karen Mattock; Lee Rosas; Raelene Wing; Sulabha Pawar; Anne Hampshire
Journal:  BMC Pediatr       Date:  2018-03-06       Impact factor: 2.125

5.  Moraxella catarrhalis phase-variable loci show differences in expression during conditions relevant to disease.

Authors:  Aimee Tan; Luke V Blakeway; Yuedong Yang; Yaoqi Zhou; John M Atack; Ian R Peak; Kate L Seib
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

6.  The Impact of Hearing Impairment on the Life Trajectories of Aboriginal Children in Remote Australia: Protocol for the Hearing Loss in Kids Project.

Authors:  Jiunn-Yih Su; Vincent Yaofeng He; Steven Guthridge; Sven Silburn
Journal:  JMIR Res Protoc       Date:  2020-01-15

7.  Absent otoacoustic emissions predict otitis media in young Aboriginal children: a birth cohort study in Aboriginal and non-Aboriginal children in an arid zone of Western Australia.

Authors:  Deborah Lehmann; Sharon Weeks; Peter Jacoby; Dimity Elsbury; Janine Finucane; Annette Stokes; Ruth Monck; Harvey Coates
Journal:  BMC Pediatr       Date:  2008-08-28       Impact factor: 2.125

8.  Inequalities in ventilation tube insertion procedures between Aboriginal and non-Aboriginal children in New South Wales, Australia: a data linkage study.

Authors:  Kathleen Falster; Deborah Randall; Emily Banks; Sandra Eades; Hasantha Gunasekera; Jennifer Reath; Louisa Jorm
Journal:  BMJ Open       Date:  2013-11-27       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.